These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 1557449)

  • 1. Perceptual bisection in rats: the effects of physostigmine, scopolamine and pirenzepine.
    Shurtleff D; Raslear TG; Genovese RF; Simmons L
    Physiol Behav; 1992 Feb; 51(2):381-90. PubMed ID: 1557449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sexually diergic hypothalamic-pituitary-adrenal axis responses to selective and non-selective muscarinic antagonists prior to cholinergic stimulation by physostigmine in rats.
    Smail MA; Soles JL; Karwoski TE; Rubin RT; Rhodes ME
    Brain Res Bull; 2018 Mar; 137():23-34. PubMed ID: 29122691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholinergic drug effects on a delayed conditional discrimination task in the rat.
    Herremans AH; Hijzen TH; Olivier B; Slangen JL
    Behav Neurosci; 1995 Jun; 109(3):426-35. PubMed ID: 7662153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discriminative stimulus properties of physostigmine in rats.
    Tang AH; Franklin SR
    Eur J Pharmacol; 1988 Aug; 153(1):97-104. PubMed ID: 3215280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative behavioral and neurochemical activities of cholinergic antagonists in rats.
    Bymaster FP; Heath I; Hendrix JC; Shannon HE
    J Pharmacol Exp Ther; 1993 Oct; 267(1):16-24. PubMed ID: 7901390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopaminergic and cholinergic interaction in cataleptic responses in mice.
    Ushijima I; Kawano M; Kaneyuki H; Suetsugi M; Usami K; Hirano H; Mizuki Y; Yamada M
    Pharmacol Biochem Behav; 1997 Sep; 58(1):103-8. PubMed ID: 9264077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscarinic receptor subtypes and sexual behavior in female rats.
    Dohanich GP; McMullan DM; Cada DA; Mangum KA
    Pharmacol Biochem Behav; 1991 Jan; 38(1):115-24. PubMed ID: 1708147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scopolamine-physostigmine combination does not substitute for nicotine.
    Schechter MD
    Prog Neuropsychopharmacol Biol Psychiatry; 1995 May; 19(3):499-508. PubMed ID: 7624500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic injection of pirenzepine induces a deficit in passive avoidance learning in rats.
    Worms P; Gueudet C; Pério A; Soubrié P
    Psychopharmacology (Berl); 1989; 98(2):286-8. PubMed ID: 2502800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic discrimination between receptor heterogeneity and allosteric interaction: resultant analysis of gallamine and pirenzepine antagonism of muscarinic responses in rat trachea.
    Kenakin T; Boselli C
    J Pharmacol Exp Ther; 1989 Sep; 250(3):944-52. PubMed ID: 2778720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of spatial learning by the M1 muscarinic antagonist pirenzepine.
    Hagan JJ; Jansen JH; Broekkamp CL
    Psychopharmacology (Berl); 1987; 93(4):470-6. PubMed ID: 3124181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of scopolamine and physostigmine on recognition memory in monkeys with ibotenic-acid lesions of the nucleus basalis of Meynert.
    Aigner TG; Mitchell SJ; Aggleton JP; DeLong MR; Struble RG; Price DL; Wenk GL; Mishkin M
    Psychopharmacology (Berl); 1987; 92(3):292-300. PubMed ID: 3114781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of intracerebroventricular pirenzepine on muscarinic discriminations in rats.
    Jung M; Perio A; Terranova JP; Worms P; Biziere K
    Eur J Pharmacol; 1987 Jul; 139(1):111-6. PubMed ID: 3653237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective M1 muscarinic receptor antagonists disrupt memory consolidation of inhibitory avoidance in rats.
    Roldán G; Bolaños-Badillo E; González-Sánchez H; Quirarte GL; Prado-Alcalá RA
    Neurosci Lett; 1997 Jul; 230(2):93-6. PubMed ID: 9259472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of azaprophen, scopolamine and trihexyphenidyl on schedule-controlled behavior, before and after chronic physostigmine.
    Genovese RF
    Eur J Pharmacol; 1990 Feb; 176(3):271-9. PubMed ID: 2328755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of infusion of cholinergic drugs into the prefrontal cortex area on delayed matching to position performance in the rat.
    Herremans AH; Hijzen TH; Welborn PF; Olivier B; Slangen JL
    Brain Res; 1996 Mar; 711(1-2):102-11. PubMed ID: 8680852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of cholinergic drugs upon recognition memory in rats.
    Huston AE; Aggleton JP
    Q J Exp Psychol B; 1987 Nov; 39(4):297-314. PubMed ID: 2829289
    [No Abstract]   [Full Text] [Related]  

  • 18. Central cholinergic involvement in working memory: effects of scopolamine on continuous nonmatching and discrimination performance in the rat.
    Spencer DG; Pontecorvo MJ; Heise GA
    Behav Neurosci; 1985 Dec; 99(6):1049-65. PubMed ID: 3843539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic characterization and functional role of muscarinic autoreceptors in the rabbit striatum.
    James MK; Cubeddu LX
    J Pharmacol Exp Ther; 1987 Jan; 240(1):203-15. PubMed ID: 3806384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physostigmine challenge before and after chronic cholinergic blockade in elderly volunteers.
    Dukoff R; Wilkinson CW; Lasser R; Friz J; Conway A; Bahro M; Peskind ER; Sunderland T
    Biol Psychiatry; 1999 Jul; 46(2):189-95. PubMed ID: 10418693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.